PKAPX
Price
$14.00
Change
-$0.03 (-0.21%)
Updated
Jul 25 closing price
Net Assets
1.39B
RMFCX
Price
$60.41
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

PKAPX vs RMFCX

Header iconPKAPX vs RMFCX Comparison
Open Charts PKAPX vs RMFCXBanner chart's image
PIMCO RAE US I-2
Price$14.00
Change-$0.03 (-0.21%)
VolumeN/A
Net Assets1.39B
American Funds American Mutual R3
Price$60.41
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
PKAPX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PKAPX vs. RMFCX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKAPX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 111B vs. PKAPX (1.39B). PKAPX pays higher dividends than RMFCX: PKAPX (1.59) vs RMFCX (1.27). PKAPX was incepted earlier than RMFCX: PKAPX (10 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than PKAPX (0.51). PKAPX is a more actively managed with annual turnover of: 73.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than PKAPX: RMFCX (250) vs PKAPX (1000000). RMFCX annual gain was more profitable for investors over the last year : 11.38 vs. PKAPX (-1.35). RMFCX return over 5 years is better than : 60.49 vs. PKAPX (54.58).
PKAPXRMFCXPKAPX / RMFCX
Total Expense Ratio0.500.9155%
Annual Report Gross Expense Ratio0.510.9156%
Fund Existence10 years23 years-
Gain YTD7.44411.34766%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B111B1%
Annual Yield % from dividends1.591.27125%
Returns for 1 year-1.3511.38-12%
Returns for 3 years22.6130.8773%
Returns for 5 years54.5860.4990%
Returns for 10 years71.3381.8287%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
CERO7.530.11
+1.48%
CERO Therapeutics Holdings Inc
AFG126.210.44
+0.35%
American Financial Group
RWAY11.05N/A
N/A
Runway Growth Finance Corp
QETA11.12N/A
N/A
Quetta Acquisition Corp